Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs, European Journal of Immunology, vol.78, issue.4, pp.993-1004, 2012. ,
DOI : 10.1002/eji.201142057
Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis, Cancer Research, vol.71, issue.6, pp.2298-2307, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-3016
Functional Complement C1q Abnormality Leads to Impaired Immune Complexes and Apoptotic Cell Clearance, The Journal of Immunology, vol.187, issue.8, pp.4369-4373, 2011. ,
DOI : 10.4049/jimmunol.1101749
The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight, The American Journal of Pathology, vol.171, issue.3, pp.715-727, 2007. ,
DOI : 10.2353/ajpath.2007.070166
Complement, Annual Review of Biochemistry, vol.38, issue.1, pp.389-414, 1969. ,
DOI : 10.1146/annurev.bi.38.070169.002133
Molecular Organization and Function of the Complement System, Annual Review of Biochemistry, vol.57, issue.1, pp.321-347, 1988. ,
DOI : 10.1146/annurev.bi.57.070188.001541
Therapeutic inhibition of the complement system, Pharmacol. Rev, vol.50, pp.59-87, 1998. ,
Cell Surface Expression and Function of the Macromolecular C1 Complex on the Surface of Human Monocytes, Frontiers in Immunology, vol.3, p.38, 2012. ,
DOI : 10.3389/fimmu.2012.00038
Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation, Clin. Exp. Rheumatol, vol.21, pp.225-228, 2003. ,
The mannan-binding-lectin pathway of the innate immune response, Current Opinion in Immunology, vol.13, issue.1, pp.74-78, 2001. ,
DOI : 10.1016/S0952-7915(00)00185-0
Control of Recombinant Monoclonal Antibody Effector Functions by Fc N-Glycan Remodeling in Vitro, Biotechnology Progress, vol.21, issue.6, pp.1644-1652, 2005. ,
DOI : 10.1021/bp050228w
Sugar-mediated ligand???receptor interactions in the immune system, Trends in Biotechnology, vol.22, issue.10, pp.524-530, 2004. ,
DOI : 10.1016/j.tibtech.2004.07.012
Characterization, chemical modifications and in vitro anticoagulant properties of an exopolysaccharide produced by Alteromonas infernus, Biochim Biophys Acta, pp.141-51, 1528. ,
Bacterial Exopolysaccharides: Functionality and Prospects, International Journal of Molecular Sciences, vol.13, issue.12, pp.14002-14015, 2012. ,
DOI : 10.3390/ijms131114002
Enhancing effect of new biological response modifier sulfoethylated (1?.3)- beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses, Exp. Oncol, vol.28, pp.308-313, 2006. ,
Antitumor and immunostimulant activities of polysaccharide produced by a marine bacterium of the genus Vibrio., NIPPON SUISAN GAKKAISHI, vol.50, issue.6, pp.1035-1037, 1984. ,
DOI : 10.2331/suisan.50.1035
Immunomodulatory Effects of Polysaccharides Produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1, Journal of Dairy Science, vol.89, issue.8, pp.2873-81, 2006. ,
DOI : 10.3168/jds.S0022-0302(06)72560-7
Polysaccharide Immunomodulators as Therapeutic Agents: Structural Aspects and Biologic Function, Clinical Microbiology Reviews, vol.13, issue.4, pp.523-533, 2000. ,
DOI : 10.1128/CMR.13.4.523-533.2000
Systemic Effects on Bone Healing of a New Hyaluronic Acid-Like Bacterial Exopolysaccharide, Calcified Tissue International, vol.73, issue.3, pp.232-236, 2003. ,
DOI : 10.1007/s00223-002-2081-7
A New Bone-Healing Material: A Hyaluronic Acid-Like Bacterial Exopolysaccharide, Calcified Tissue International, vol.72, issue.1, pp.74-79, 2003. ,
DOI : 10.1007/s00223-001-2091-x
Production of anti-complementary exopolysacharides from submerged culture of Flammulina velutipes, Food Technol. Biotechnol, vol.45, pp.319-326, 2007. ,
Alteromonas infernus sp. nov., a new polysaccharide-producing bacterium isolated from a deep-sea hydrothermal vent, Journal of Applied Microbiology, vol.82, issue.4, pp.422-430, 1997. ,
DOI : 10.1046/j.1365-2672.1997.00125.x
Vibrio diabolicus sp. nov., a New Polysaccharide-Secreting Organism Isolated from a Deep-Sea Hydrothermal Vent Polychaete Annelid, Alvinella pompejana, International Journal of Systematic Bacteriology, vol.47, issue.4, pp.989-995, 1997. ,
DOI : 10.1099/00207713-47-4-989
Structure/function studies of anticoagulant sulphated polysaccharides using NMR, Journal of Biotechnology, vol.77, issue.1, pp.123-135, 2000. ,
DOI : 10.1016/S0168-1656(99)00211-4
Structure of the exopolysaccharide of Vibriodiabolicus isolated from a deep-sea hydrothermal vent, Carbohydrate Research, vol.322, issue.1-2, pp.40-45, 1999. ,
DOI : 10.1016/S0008-6215(99)00214-1
Protein measurement with the Folin phenol reagent, J Biol Chem, vol.193, pp.265-275, 1951. ,
Estimation of the Sulfate Content of Hydrothermal Vent Bacterial Polysaccharides by Fourier Transform Infrared Spectroscopy, Analytical Biochemistry, vol.220, issue.2, pp.244-248, 1994. ,
DOI : 10.1006/abio.1994.1334
Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum, Carbohydrate Research, vol.289, pp.201-208 ,
DOI : 10.1016/0008-6215(96)00110-3
New investigations on heparinlike derivatized dextrans: CMDBS, synergistic role of benzylamide and sulfate substituents in anticoagulant activity. Carbohydr, Polymers, vol.32, pp.89-93, 1997. ,
High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes, Blood, vol.88, pp.184-193, 1996. ,
Heparin Binding and Augmentation of C1 Inhibitor Activity, Archives of Biochemistry and Biophysics, vol.361, issue.2, pp.215-222, 1999. ,
DOI : 10.1006/abbi.1998.0996
The ??-gal epitope (Gal??1-3Gal??1-4GlcNAc-R) in xenotransplantation, Biochimie, vol.83, issue.7, pp.557-563, 2001. ,
DOI : 10.1016/S0300-9084(01)01294-9
Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans, Transplant Proc, vol.24, pp.559-562, 1992. ,
Complement dependent cytotoxicity activity of therapeutic antibody fragments is acquired by immunogenic glycan coupling, Electron. J Biotechnol, vol.15, pp.1-11, 2012. ,
Review: ABO blood group system?ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes, Immunohematol, vol.20, pp.3-22, 2004. ,
Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A, Infect. Immun, vol.53, pp.480-485, 1986. ,
Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate, Thrombosis Research, vol.122, issue.1, pp.109-116 ,
DOI : 10.1016/j.thromres.2007.09.001
Letter to the Glyco-Forum: Biological properties of sulfated fucans: the potent inhibiting activity of algal fucoidan against the human complement system, Glycobiology, vol.13, issue.12, pp.29-30, 2003. ,
DOI : 10.1093/glycob/cwg126
Relationships between chemical characteristics and anticomplementary activity of fucans, Biomaterials, vol.17, issue.6, pp.597-603, 1996. ,
DOI : 10.1016/0142-9612(96)88710-2
Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1, J Immunol, vol.158, pp.1324-1331, 1997. ,
Complement C3b interactions studied with surface plasmon resonance technique, International Immunopharmacology, vol.1, issue.3, pp.495-506, 2001. ,
DOI : 10.1016/S1567-5769(00)00042-4
Heparin Binding and Augmentation of C1 Inhibitor Activity, Archives of Biochemistry and Biophysics, vol.361, issue.2, pp.215-222, 1999. ,
DOI : 10.1006/abbi.1998.0996
Surface plasmon resonance: towards an understanding of the mechanisms of biological molecular recognition, Current Opinion in Chemical Biology, vol.5, issue.5, pp.572-577, 2001. ,
DOI : 10.1016/S1367-5931(00)00251-9